The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksChesnara Regulatory News (CSN)

Share Price Information for Chesnara (CSN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 252.00
Bid: 250.00
Ask: 252.00
Change: 1.00 (0.40%)
Spread: 2.00 (0.80%)
Open: 254.00
High: 255.00
Low: 248.50
Prev. Close: 251.00
CSN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

1 May 2018 07:00

RNS Number : 6446M
Chesnara PLC
01 May 2018
 

 

 

Chesnara plc

 

Notification of Transactions of Directors/Persons Discharging Managerial Responsibility ('PDMRs')

 

Chesnara plc (the 'Company') today announces that, as at 30 April 2018, John Deane and David Rimmington (each a PDMR) were granted awards in the ordinary shares of the Company under the Chesnara plc Long Term and Short Term Schemes. These awards were made in accordance with the Directors' Remuneration Policy.

 

The notifications for each PDMR below, which are being made in accordance with the requirements of the EU Market Abuse Regulations, provide further detail of the awards granted to each PDMR.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

b)

Natural person:

Legal person

John Deane

2

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/amendment

Initial notification

3

Details of the Issuer

a)

Name

Chesnara plc

b)

Legal Entity Identifier:

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): Parts a-d of this section are to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument (Identification code)

Chesnara plc Ordinary Shares of 5 pence each

 

(GB00B00FPT80)

b)

Nature of the transaction

 

GRANT 1

GRANTED UNDER THE CHESNARA 2014 SHORT-TERM INCENTIVE SCHEME. THE OPTION IS NOT SUBJECT TO A PERFORMANCE TARGET.

 

THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2021 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2028 IF NOT EXERCISED BEFORE THAT DATE.

 

GRANT 2

GRANTED UNDER THE CHESNARA 2014 LONG-TERM INCENTIVE SCHEME. THE OPTION IS SUBJECT TO A PERFORMANCE TARGET OVER A PERIOD OF THREE FINANCIAL YEARS.

 

SUBJECT TO THE ACHIEVEMENT OF THE PERFORMANCE TARGET, THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2021 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2028 IF NOT EXERCISED BEFORE THAT DATE.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

GRANT 1

31,802 ORDINARY SHARES OF 5P EACH

Nil

GRANT 2

107,100 ORDINARY SHARES OF 5P EACH

d)

Aggregated information

- Aggregated volume

- Price

 

- 138,902 ORDINARY SHARES OF 5P EACH

 

- Nil

e)

Date of the transaction (YYYY - MM - DD)

2017-04-30

f)

Place of the transaction

XOFF

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

b)

Natural person:

Legal person

David Rimmington

2

Reason for the notification

a)

Position/status:

Chief Finance Officer

b)

Initial notification/amendment

Initial notification

3

Details of the Issuer

a)

Name

Chesnara plc

b)

Legal Entity Identifier:

213800VFRMBRTSZ3SJ06

4

Details of the transaction(s): Parts a-d of this section are to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted.

a)

Description of the financial instrument, type of instrument (Identification code)

Chesnara plc Ordinary Shares of 5 pence each

 

(GB00B00FPT80)

b)

Nature of the transaction

 

GRANT 1

GRANTED UNDER THE CHESNARA 2014 SHORT-TERM INCENTIVE SCHEME. THE OPTION IS NOT SUBJECT TO A PERFORMANCE TARGET.

 

THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2021 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2028 IF NOT EXERCISED BEFORE THAT DATE.

 

GRANT 2

GRANTED UNDER THE CHESNARA 2014 LONG-TERM INCENTIVE SCHEME. THE OPTION IS SUBJECT TO A PERFORMANCE TARGET OVER A PERIOD OF THREE FINANCIAL YEARS.

 

SUBJECT TO THE ACHIEVEMENT OF THE PERFORMANCE TARGET, THE OPTION WILL BECOME EXERCISABLE ON 28 APRIL 2021 AND REMAIN EXERCISABLE UP TO AND INCLUDING 27 APRIL 2028 IF NOT EXERCISED BEFORE THAT DATE.

c)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

GRANT 1

17,620 ORDINARY SHARES OF 5P EACH

 

Nil

GRANT 2

60,805 ORDINARY SHARES OF 5P EACH

 

d)

Aggregated information

- Aggregated volume

- Price

 

- 78,425 ORDINARY SHARES OF 5P EACH

 

- Nil

e)

Date of the transaction (YYYY - MM - DD)

2017-04-30

f)

Place of the transaction

XOFF

 

 

Name of authorised official of issuer responsible for making notification

Al Lonie

 

Date of notification 1 May 2018

 

 

 

 

 

Notes to Editors

Chesnara plc ('Chesnara'), which listed on the London Stock Exchange in May 2004, is the owner of Countrywide Assured plc ('CA plc'), Movestic Livförsäkringar AB ('Movestic') and Chesnara Holdings BV. Chesnara Holdings BV is the intermediate holding company of 'Waard Group' and 'Scildon'.

 

CA plc is a UK life assurance subsidiary that is closed to new business. In June 2005 Chesnara acquired a further closed life insurance company - City of Westminster Assurance - for £47.8m. With effect from 30 June 2006, CWA's policies and assets were transferred into CA plc. Save & Prosper Insurance Limited and its subsidiary, Save & Prosper Pensions Limited, were acquired on 20 December 2010 for £63.5 million. With effect from 31 December 2011, the business of Save & Prosper was transferred into CA plc. On 28 November 2013 Chesnara acquired Direct Line Life Insurance Company Limited (subsequently renamed Protection Life Company Limited) from Direct Line Group plc for £39.3m. On 31 December 2014 the PL business transferred into CA plc. CA plc operates an outsourced business model.

 

Movestic, a Swedish life assurance company which originally focused on pensions and savings, was acquired on 23 July 2009 for £20 million. The company is open to new business and seeks to grow its position in the Swedish unit-linked market. Its proposition was strengthened in February 2010 with the acquisition of the operations of Aspis Försäkringar Liv AB which has a risk and health product bias.

 

The Waard Group, a Netherlands-based Group comprising three closed book insurance companies and a servicing company, was acquired on 19 May 2015 for €69.9m. The Waard Group, comprising Waard Leven N.V., Hollands Welvaren Leven N.V., Waard Schade N.V. and Tadas Verzekeringen B.V. was previously owned by DSB Beheer B.V., a Dutch financial services Group. The policy base of the Waard Group is predominantly term life policies, with some unit linked policies and some non-life policies. On 5 April 2017 Chesnara completed its acquisition of Legal & General Nederland Levensverzeikering Maatschappij N.V. ('LGN') for €161.2 million. The LGN business which has been renamed Scildon, is in the Dutch life assurance market, and as with our Swedish subsidiary Movestic, Scildon writes protection and pension new business.

 

Further details are available on the Company's website (www.chesnara.co.uk).

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHWGURGCUPRGQU
Date   Source Headline
31st Mar 20237:00 amRNSTotal Voting Rights
30th Mar 20237:00 amRNSFinal Results
1st Mar 20237:00 amRNSNotice of Results
28th Feb 20237:00 amRNSTotal Voting Rights
17th Feb 20237:00 amRNSHolding(s) in Company
31st Jan 20237:00 amRNSTotal Voting Rights
3rd Jan 20237:00 amRNSTotal Voting Rights
19th Dec 20227:00 amRNSHolding(s) in Company
16th Dec 20227:00 amRNSAcquisition
30th Nov 20227:00 amRNSTotal Voting Rights
15th Nov 20227:00 amRNSHolding(s) in Company
14th Nov 20227:00 amRNSDirector/PDMR Shareholding
11th Nov 20227:00 amRNSDirector/PDMR Shareholding
1st Nov 202212:15 pmRNSDirector/PDMR Shareholding
31st Oct 20227:00 amRNSTotal Voting Rights
27th Oct 20222:45 pmRNSDirector/PDMR Shareholding
24th Oct 20227:00 amRNSBlock listing Interim Review
19th Oct 20227:00 amRNSDirector/PDMR Shareholding
3rd Oct 20227:00 amRNSAppointment of Group GC & Company Secretary
29th Sep 20227:00 amRNSBlock Listing Application
12th Sep 20227:15 amEQSHardman & Co Research on Chesnara Plc (CSN): Robust cash generation in challenging markets
8th Sep 202212:05 pmEQSHardman Talks Video: Interview Chesnara management discuss 2022 half-year results
2nd Sep 20227:00 amRNSHolding(s) in Company
31st Aug 20227:00 amRNSHalf-year Report
23rd Aug 20227:00 amRNSHolding(s) in Company
17th Aug 20227:00 amRNSNotice of Interim Results
15th Aug 20222:45 pmEQSHardman & Co: Q&A on Chesnara Plc (CSN) Conservatrix acquisition boosts AuA and cash flow with capacity for more
8th Aug 20227:00 amRNSHolding(s) in Company
5th Aug 20227:00 amRNSHolding(s) in Company
2nd Aug 20227:00 amRNSChesnara Enhances M&A and Commercial Capabilities
29th Jul 20227:15 amEQSHardman & Co Research: Chesnara plc (CSN): Another fine acquisition
22nd Jul 20227:00 amRNSAcquisition
16th Jun 20229:15 amEQSHardman & Co Research: Q&A on Chesnara Plc (CSN): Good performance analysed
31st May 20227:00 amRNSTotal Voting Rights
24th May 20227:00 amEQSHardman & Co Research : Chesnara plc (CSN): Market benefits overwhelm operational challenges
17th May 20221:51 pmRNSResult of AGM
29th Apr 20227:00 amRNSDirector/PDMR Shareholding
28th Apr 20227:00 amRNSAcquisition Completions
22nd Apr 20227:00 amRNSBlock listing Interim Review
21st Apr 20227:00 amRNSNotice of AGM
8th Apr 20227:00 amRNSAcquisition Update
5th Apr 20222:30 pmRNSDirector/PDMR Shareholding
31st Mar 20227:00 amRNSFinal Results
17th Mar 20227:00 amRNSNotice of Results
15th Mar 20227:00 amRNSTotal Voting Rights
14th Feb 20227:00 amRNSDirectorate Change
2nd Feb 20223:07 pmRNS£200m Inaugural Tier 2 Subordinated Notes Issuance
26th Jan 20227:00 amRNSHolding(s) in Company
17th Jan 20227:00 amRNSDirectorate Change
17th Dec 20217:00 amRNSSenior Leadership Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.